Biochemistry
-
Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design
This article has 10 authors:Reviewed by ScreenIT
-
Conformational diversity of CDR region during affinity maturation determines the affinity and stability of Sars-Cov-1 VHH-72 nanobody
This article has 1 author:Reviewed by ScreenIT
-
Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication
This article has 4 authors:Reviewed by ScreenIT
-
Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects
This article has 4 authors:Reviewed by ScreenIT
-
High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
This article has 5 authors:Reviewed by ScreenIT
-
SARS-CoV-2 spike-glycoprotein processing at S1/S2 and S2’and shedding of the ACE2 viral receptor: roles of Furin and TMPRSS2 and implications for viral infectivity and cell-to-cell fusion
This article has 18 authors:Reviewed by ScreenIT
-
Potent in vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L
This article has 19 authors:Reviewed by ScreenIT
-
Structural basis for the inhibition of the papain-like protease of SARS-CoV-2 by small molecules
This article has 15 authors:Reviewed by ScreenIT
-
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
This article has 10 authors:Reviewed by ScreenIT
-
TMPRSS2 and ADAM17 interactions with ACE2 complexed with SARS-CoV-2 and B 0 AT1 putatively in intestine, cardiomyocytes, and kidney
This article has 1 author:Reviewed by ScreenIT